North America Surgical Gowns Market Size, Share, and Growth Forecast, 2026 – 2033

The North America surgical gowns market size is likely to be valued at US$910.1 million in 2026 and is projected to reach US$1,529.7 million by 2033, growing at a CAGR of 7.7% during the forecast period 2026 – 2033, driven by rising surgical volumes, stronger infection-prevention practices, and growing adoption of gowns with defined liquid-barrier performance. The U.S. alone recorded more than 92.3 million surgical procedures in 2024, highlighting the substantial recurring demand for surgical gowns across hospitals and ambulatory surgery centers. Disposable surgical gowns remain widely used in high-throughput settings, while reusable gowns are gaining traction as healthcare systems pursue validated laundering and sustainability programs.

Driver: Growth in surgical and ambulatory procedures is expanding recurring gown consumption

The steady rise in surgical procedures, together with the shift toward ambulatory surgery centers (ASCs), is supporting recurring demand for surgical gowns across North America. The Medicare Payment Advisory Commission reported a 3.4% increase in ASC volume per 1,000 Medicare fee-for-service beneficiaries in 2024, showing that outpatient procedures continue to gain momentum. As more procedures are performed in ASCs, these facilities need a reliable supply of sterile gowns that provide the right level of protection for different types of procedures.

Another important trend is the growing preference for ready-to-use surgical gowns that can help staff maintain efficient operating-room workflows and reduce preparation time. ASCs, in particular, are looking for products that are easy to stock, quickly available, and consistent across multiple facilities. Manufacturers are responding by improving gown designs with breathable materials, better fit, ergonomic features, improved sleeve construction, and greater wearer comfort. These changes are making surgical gowns more than basic protective apparel, with product performance increasingly tied to efficiency and comfort during surgical procedures.

Restraint: Increasing regulatory scrutiny and product-quality requirements raise compliance complexity

Meeting regulatory and quality requirements continues to be a challenge for surgical-gown manufacturers. Products must consistently deliver the required barrier protection, strength, sterility, labeling, and overall performance. The U.S. Food and Drug Administration (FDA) classifies surgical gowns as Class II medical devices, while standards such as ANSI/AAMI PB70:2022 and the recently recognized ASTM F2407/F2407M-23a establish important requirements for gown performance and testing.

Recent events have also put greater attention on manufacturing controls and product quality. In 2025, the U.S. Department of Justice announced a settlement involving Kimberly-Clark over allegations related to adulterated MicroCool surgical gowns, with the company agreeing to pay up to US$40.4 million. The case illustrates the financial and reputational risks that can arise when medical-device quality requirements are not properly met. Manufacturers therefore need strong systems for material testing, production controls, product traceability, and quality assurance. These requirements can add time and cost to product development, especially for gowns designed to provide higher levels of fluid protection.

Opportunity: Product innovation and validated reusable programs are creating new procurement opportunities

Product innovation is opening new opportunities for manufacturers to compete on protection, comfort, and ease of use rather than price alone. In 2025, Medline received FDA clearance for a Level 4 surgical gown with breathable sleeves, reflecting the industry's growing focus on combining high-level fluid protection with better breathability. This type of innovation is particularly useful during lengthy or fluid-intensive procedures, where clinicians need strong protection without sacrificing comfort.

The growing interest in reusable surgical gowns and textile-management programs also creates another avenue for market development. Hospitals are increasingly evaluating reusable options where they have reliable systems for laundering, inspection, tracking, and redistribution. Well-managed reusable programs can support consistent garment availability while reducing the need to repeatedly purchase disposable products. At the same time, disposable gowns continue to appeal to facilities that value convenience, quick availability, and simpler handling. This allows suppliers to build broader product portfolios that offer disposable and reusable gowns suited to different procedures, protection levels, and facility requirements.

Product Type Insights

Disposable surgical gowns represent the leading product type, primarily because they are easier to deploy across high-volume operating rooms, emergency procedures, and facilities with frequent patient turnover. Their single-use format eliminates laundering, inspection, and garment-reprocessing requirements, while providing a consistent level of protection for each procedure. The broader North American hospital-gown market provides a directional benchmark, with disposable gowns accounting for 71% of demand in 2026. Their established use, straightforward inventory management, and strong preference for sterile ready-to-use products help disposable gowns maintain the largest share of the surgical-gown category.

Reusable surgical gowns are expected to be the fastest-growing product type, supported by growing attention to sustainability, textile waste, and the long-term cost of repeatedly purchasing single-use products. Adjacent North American hospital-gown data indicate an 8.38% CAGR through 2033 for reusable gowns. Their growth is strongest among health systems that already have validated laundering, inspection, tracking, and redistribution infrastructure. Hospitals with centralized textile-management programs can integrate reusable gowns into existing workflows more easily, making this format increasingly attractive where lifecycle economics and waste reduction are important procurement considerations.

Protection Level Insights

AAMI Level 3 is positioned as the leading protection level, supported by its suitability for a broad range of moderate-risk clinical situations and procedures involving greater exposure to fluids than Level 1 and Level 2 applications. The FDA identifies Level 3 for situations such as arterial blood draws, intravenous line insertion, emergency-room procedures, and trauma care. Its balance of fluid protection, flexibility, breathability, and cost makes it suitable for healthcare facilities that need stronger protection without moving to the highest-barrier Level 4 products across all procedures.

AAMI Level 4 is expected to be the fastest-growing protection level, as healthcare providers increasingly prioritize stronger fluid barriers for complex and high-exposure procedures. The FDA identifies Level 4 for high-risk applications involving long, fluid-intensive procedures and surgery where pathogen resistance is required. Demand is particularly supported by orthopedic, cardiovascular, trauma, and other complex procedures. Product development is also moving toward combining high barrier performance with better breathability and mobility. The recognition of ASTM F2407/F2407M-23a further reinforces performance requirements for surgical gowns, with Level 4 requiring additional testing using simulated biological fluids.

End-user Insights

Hospitals represent the leading end-user segment because they conduct the widest range of surgical and invasive procedures and operate multiple departments where protective gowns are routinely required. Operating rooms, emergency departments, intensive-care units, and specialty surgical units create continuous demand across different protection levels. Hospitals also tend to purchase through centralized procurement contracts and group purchasing arrangements, favoring suppliers that can provide broad product portfolios and dependable distribution. The broader North American hospital-gown market recorded a 61% share for hospitals and clinics in 2026, highlighting the strong purchasing base provided by institutional healthcare facilities.

Ambulatory surgery centers are expected to be the fastest-growing end-user segment, driven by the continued shift of suitable procedures from inpatient hospitals to outpatient settings. Adjacent North American hospital-gown data indicate an 8.65% CAGR through 2033 for ASC demand. ASCs typically operate with faster room turnover and leaner inventories, increasing the value of gowns that are easy to stock, quickly available, and suited to specific procedures. The expansion of orthopedic, ophthalmic, gastrointestinal, and other outpatient procedures is further supporting demand. Suppliers offering reliable replenishment, flexible order quantities, and convenient ready-to-use gown formats are well positioned to benefit from this channel.

The U.S. represents the dominant country market in North America, accounting for an estimated 84% of regional demand in 2026, based on the latest available benchmark for the broader North American hospital-gowns category. Its large hospital network, high surgical volumes, extensive ambulatory surgery center base, and established medical-device supply chains support the country's leading position. U.S. surgical activity remains substantial, with approximately 92.3 million procedures recorded across 12 major medtech categories in 2024, supporting recurring demand for sterile surgical gowns and other operating-room protective products. Recent procurement trends also show greater interest in gowns that combine barrier protection with breathability, comfort, and efficient operating-room workflows.

Canada accounts for an estimated 16% of regional demand in 2026, making it the second-largest country market in North America. The Canadian market is supported by publicly funded healthcare systems, provincial procurement programs, and continued efforts to address surgical backlogs. Recent national reporting shows that more than 2.3 million surgeries were performed in Canada during 2023-2024, approximately 5% above the 2019-2020 level. Surgical activity increased further in 2024-2025, with approximately 188,000 additional surgeries compared with 2019-2020. Canadian healthcare organizations are also showing greater interest in reusable medical textiles and structured garment-management programs, creating opportunities for suppliers offering both disposable and reusable surgical gowns.

The North America surgical gowns market includes large medical-supply companies, surgical-textile manufacturers, and specialized healthcare suppliers. Competition centers on AAMI barrier performance, regulatory compliance, product quality, supply reliability, and procurement relationships. Hospitals and ASCs increasingly favor gowns that combine protection with breathability, comfort, and efficient workflow. Suppliers are responding with higher-performance disposable gowns, reusable options, improved materials, and ergonomic designs, while strong distribution networks and long-term procurement contracts remain key to customer retention.

Key Industry Developments:

• In April 2026, Solventum opened its new 250,000-square-foot Eagan research and development hub in Minnesota and expanded its manufacturing facility in Brookings, South Dakota, strengthening its North American R&D and manufacturing capabilities and supporting the development of new healthcare and protective-material technologies.
• In March 2026, Medline entered a Prime Vendor agreement with CarDon & Associates covering 20 long-term-care communities in Indiana, expanding access to its medical-surgical portfolio and strengthening its institutional distribution network for healthcare products, including protective textiles.